Newsroom

MEUDON, France--(BUSINESS WIRE)--Thales publie le Digital Trust Index 2026, l’une des études mondiales les plus complètes sur la confiance numérique. Basé sur une enquête réalisée auprès de 15 000 consommateurs, partenaires commerciaux et DSI de 13 industries, le rapport révèle que la confiance numérique est gagnée ou perdue au moment de la connexion et tout au long du cycle de traitement des données personnelles. La confiance des consommateurs se gagne et se perd au moment de la connexion Pour...

RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today the appointment of Christopher Monoski as its new Executive Vice President, Manufacturing, further strengthening the company’s ability to deliver secure, mission-critical technologies across defense, intelligence, and national security programs. Monoski will report directly to President and Chief Executive Officer John Mengucci and will serve as a key member of CACI’s leadership team, responsible for building and...

FALLS CHURCH, Va.--(BUSINESS WIRE)--Vierra Falls Church Health & Rehab is pleased to announce that Dr. Walid Alami, MD, FACC, FSCAI, a renowned board-certified interventional cardiologist, has joined its clinical team, marking a significant expansion of the facility’s cardiac capabilities. His arrival enhances the center’s well-established suite of specialized programs, including orthopedic rehabilitation, renal care, wound care, chronic condition management, and infectious disease. Dr. Ala...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Guardant360® CDx liquid biopsy test as a companion diagnostic for VEPPANU (vepdegestrant). VEPPANU, jointly developed by Arvinas, Inc. and Pfizer Inc., is approved for the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), estrogen receptor...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 (formerly CTC-501) in patients with Major Depressive Disorder (MDD). The data were presented in a poster session at the 2026 Annual Meeting of the Society of Biological Psychiatry (SOBP). ALTO-20...

PLANO, Texas--(BUSINESS WIRE)--Airspan Networks Holdings LLC (“Airspan”) and Wireless Services today announced the successful deployment of Airspan’s MobileAccess 6000 Digital DAS platform at Charlotte Douglas International Airport (CLT). Delivered as part of a long-standing collaboration, the deployment marks a major milestone in CLT’s ongoing wireless infrastructure modernization, enhancing coverage and capacity throughout the airport. At the core of the deployment is Airspan’s MobileAccess 6...

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the Phase 1 study of XmAb942, a novel, potential best-in-class, long-acting anti-TL1A antibody for the treatment of inflammatory bowel disease (IBD). The results are being presented today at Digestive Disease Week® (DDW), being held in Chicago. Tomorrow, the company will a...

WASHINGTON--(BUSINESS WIRE)--Clean Air Partners' new campaign highlights the surprising culprits of air pollution and greenhouse gas emissions found right in our own backyards....

NEW YORK--(BUSINESS WIRE)--TOMS Capital Investment Management (“TCIM”), one of the largest shareholders of Voya Financial, Inc. (NYSE: VOYA), today issued the following statement: “Despite the underlying strength of the franchise, Voya has deeply impaired its earnings multiple due to the lack of urgency and indecisiveness of management and the Board of Directors, particularly around the stop-loss business. This has eroded credibility with both Voya’s investor base and the research community. As...

HOUSTON--(BUSINESS WIRE)--DXP Enterprises, Inc. (the “Company”) (NASDAQ: DXPE), a leading business to business products and service distributor that adds value and total cost savings solutions to MRO and OEM customers in virtually every industry, plans to issue a press release announcing its financial results for the first quarter ended March 31, 2026, on Thursday, May 7th. The earnings announcement will be released before the market opens. DXP will host a conference call, to be webcast live, o...